Mary Ziping Luo
2013
In 2013, Mary Ziping Luo earned a total compensation of $2.4M as Chief Operating Officer, Chief Scientist and Chairman at Amphastar Pharmaceuticals.
Compensation breakdown
| Bonus | $273,780 |
|---|---|
| Salary | $671,943 |
| Stock Awards | $1,400,000 |
| Other | $34,126 |
| Total | $2,379,849 |
Luo received $1.4M in stock awards, accounting for 59% of the total pay in 2013.
Luo also received $273.8K in bonus, $671.9K in salary and $34.1K in other compensation.
Rankings
In 2013, Mary Ziping Luo's compensation ranked 3,285th out of 12,286 executives tracked by ExecPay. In other words, Luo earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,285 out of 12,286 | 73rd |
Division Manufacturing | 1,114 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 294 out of 1,466 | 80th |
Industry group Drugs | 201 out of 1,160 | 83rd |
Industry Pharmaceutical Preparations | 168 out of 890 | 81st |
Source: SEC filing on April 8, 2015.
Luo's colleagues
We found two more compensation records of executives who worked with Mary Ziping Luo at Amphastar Pharmaceuticals in 2013.
News
Amphastar Pharmaceuticals CEO Jack Zhang's 2021 pay rises 9% to $6.5M
April 14, 2022
Amphastar Pharmaceuticals General Counsel Jason Shandell's 2020 pay jumps 132% to $6.8M
April 14, 2021
Amphastar Pharmaceuticals CEO Jack Zhang's 2019 pay rises 2% to $6M
April 15, 2020
Amphastar Pharmaceuticals CEO Jack Zhang's 2018 pay rises 2% to $5.9M
April 18, 2019